Cancer control : journal of the Moffitt Cancer Center
Jan 1, 2022
INTRODUCTION: Cancer is a major public health problem and a global leading cause of death where the screening, diagnosis, prediction, survival estimation, and treatment of cancer and control measures are still a major challenge. The rise of Artificia...
Methods in molecular biology (Clifton, N.J.)
Jan 1, 2022
Complex, distributed, and dynamic sets of clinical biomedical data are collectively referred to as multimodal clinical data. In order to accommodate the volume and heterogeneity of such diverse data types and aid in their interpretation when they are...
Artificial intelligence (AI) powered by the accumulating clinical and molecular data about cancer has fueled the expectation that a transformation in cancer treatments towards significant improvement of patient outcomes is at hand. However, such tran...
Combinatorial chemistry & high throughput screening
Jan 1, 2022
Cancer is a vast form of the disease that can begin in almost any organ or tissue of the body when abnormal cells grow uncontrollably and attack nearby organs. The traditional approaches to cancer diagnosis and drug development have certain limitatio...
Advances in experimental medicine and biology
Jan 1, 2022
Precision oncology is an innovative approach to cancer care in which diagnosis, prognosis, and treatment are informed by the individual patient's genetic and molecular profile. The rapid development of novel high-throughput omics technologies in rece...
Cancer biomarkers : section A of Disease markers
Jan 1, 2022
BACKGROUND: With the use of artificial intelligence and machine learning techniques for biomedical informatics, security and privacy concerns over the data and subject identities have also become an important issue and essential research topic. Witho...
Cancer is a deadly disease that is often caused by the accumulation of various genetic mutations and pathological alterations. The death rate can only be reduced when it is detected in the early stages, because cancer treatment when the tumor has not...
PURPOSE: Despite advances in molecular therapeutics, few anticancer agents achieve durable responses. Rational combinations using two or more anticancer drugs have the potential to achieve a synergistic effect and overcome drug resistance, enhancing ...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.